ID
44998
Descripción
Principal Investigator: Ulrike Peters, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA MeSH: Colorectal Neoplasms,Sequence Analysis, DNA https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000410 This project was designed to use next generation sequencing technology to screen the protein coding regions of the genome for low frequency variants in a panel of high-risk colorectal adenocarcinoma cases. Blood and cell-line DNA for colorectal cancer patients and a subset of quality control samples that had existing whole exome sequence data were analyzed using Illumina HiSeq sequencers. Samples from this project were from participants in the Women's Health Initiative (WHI) and the Diet, Activity, and Lifestyle Study (DALS).
Link
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000410
Palabras clave
Versiones (2)
- 1/7/22 1/7/22 - Dr. Christian Niklas
- 12/10/22 12/10/22 - Adrian Schulz
Titular de derechos de autor
Ulrike Peters, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Subido en
1 de julio de 2022
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
dbGaP phs000410 Whole Exome Sequencing for Colorectal Cancer
Sample ID, analyte type, body site where from samples were collected, type of samples including tumor or normal tissue, histological type of samples obtained from participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group and affection status of participants involved in the " Whole Exome Sequencing for Colorectal Cancer" project.
- Sample ID, subject ID, sample sources, sample source ID, and IDs of samples used for whole exome sequencing and obtained from participants involved in the " Whole Exome Sequencing for Colorectal Cancer" project.
- Subject ID, case or control status, age, race, sex, and family history of colorectal cancer among participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
- Sample ID, analyte type, body site where from samples were collected, type of samples including tumor or normal tissue, histological type of samples obtained from participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
Similar models
Sample ID, analyte type, body site where from samples were collected, type of samples including tumor or normal tissue, histological type of samples obtained from participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject source, subject source ID, consent group and affection status of participants involved in the " Whole Exome Sequencing for Colorectal Cancer" project.
- Sample ID, subject ID, sample sources, sample source ID, and IDs of samples used for whole exome sequencing and obtained from participants involved in the " Whole Exome Sequencing for Colorectal Cancer" project.
- Subject ID, case or control status, age, race, sex, and family history of colorectal cancer among participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
- Sample ID, analyte type, body site where from samples were collected, type of samples including tumor or normal tissue, histological type of samples obtained from participants involved in the "Whole Exome Sequencing for Colorectal Cancer" project.
C0200345 (UMLS CUI [1,2])
C1277698 (UMLS CUI [1,3])
C0332307 (UMLS CUI [1,2])
C0012854 (UMLS CUI [1,3])
C0370003 (UMLS CUI [1,2])
C0040300 (UMLS CUI [2,1])
C0370003 (UMLS CUI [2,2])